Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · STATUTE-COMPILATIONS · FDA Reauthorization Act of 2017 · Sec. 304

Sec. 304. REAUTHORIZATION; REPORTING REQUIREMENTS

82 words·~1 min read·/statute-compilations/comps-15234/sec-304

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 304 REAUTHORIZATION; REPORTING REQUIREMENTS Section 744C of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-43) is amended— ####
(1)in subsection (a)— #####
(A)by striking “2013” and inserting “2018”; and #####
(B)by striking “Generic Drug User Fee Amendments of 2012” and inserting “Generic Drug User Fee Amendments of 2017”; ####
(2)in subsection (b), by striking “2013” and inserting “2018”; and ####
(3)in subsection (d), by striking “2017” each place it appears and inserting “2022”.
Connectionstraces to 1
Citation graph
cites case law
Sec. 304
REAUTHORIZATION; REPORTING REQUIREMENTS
U.S.C.§ 379j–43
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.